查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1736738

全球骨内装置市场：市场规模（按类型、最终用户和地区划分）、未来预测

Global Intraosseous Devices Market Size By Type (Manual, Semi-Automatic, Automatic), By End-User (Hospitals, Emergency Medical Services (EMS), Military), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3个工作天内

价格
简介目录

骨内器械的市场规模和预测

2024 年骨内设备市场规模价值 4.1282 亿美元，预计到 2032 年将达到 5.9294 亿美元，2026 年至 2032 年的复合年增长率为 4.63%。

心臟麻痹等各种疾病的高发病率、包括创伤在内的紧急情况以及日益增多的军事介入预计将推动全球骨内器械市场的成长。越来越多的政府和监管机构的核准是骨内器械市场的基础。此外，研发活动的活性化和公众健康意识的增强也推动着市场的成长。本报告对全球骨内器材市场进行了全面的评估，全面分析了关键细分市场、趋势、市场驱动因素、限制因素、竞争格局以及影响市场的关键因素。

定义全球骨内设备市场

骨内装置是用来处理危及生命状况的紧急医疗设备。在无法建立静脉通路的紧急情况下，骨内装置用于输送药物和重要液体。骨内血管是紧急情况下即时医疗介入的替代方案。此装置可快速插入骨髓腔，并透过静脉输液流入装置来指示装置的准确位置。

如果液体渗出到插入部位周围，则应移除装置以防止腔室症候群的扩散。然而，骨髓穿刺是另一种确认装置正确放置的方法。骨内装置快速、简单且有效。它们透过骨髓将药物直接注入体循环，在紧急或延误的情况下非常有用。这些装置用于治疗血液科/肿瘤科患者、创伤、心臟麻痹和糖尿病患者。

全球骨内器材市场概况

预计近期损伤发生率的上升以及静脉血管通路的失效将推动骨内器械市场的发展。当其他给药途径无法达到预期效果时，骨内输注是一种安全有效的心肺復苏术。

多种疾病（例如心臟麻痹）的高发病率、创伤等紧急情况以及军事介入的不断增加，正在推动全球骨内器械市场的发展。人均收入的提高和对先进医疗保健的投资意愿的增强也推动了需求的成长。腹腔内输液最常用于儿科院前急救，因为在这种紧急情况下，静脉注射是不可能的。多种疾病类型的盛行率上升以及创伤性手术的数量增加，可能会在未来几年推动对这些器械的需求。

诸如插入过程中的骨折、给药过程中的药物洩漏以及插入部位感染疾病等风险，以及高昂的药品成本、护理人员缺乏医疗专业知识以及设备管理不善等因素，都是骨内器械市场的潜在限制因素。日益增多的监管核准、併购以及新兴经济体创造的新市场，为市场带来了丰厚的成长机会。

目录

第一章全球骨内器械市场简介

  • 市场概览
  • 分析范围
  • 先决条件

第二章执行摘要

第三章 已验证的市场研究分析方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章全球骨内装置市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

5. 全球骨内装置市场（按类型）

  • 概述
  • 手动的
  • 半自动
  • 自动的

6. 全球骨内装置市场（依最终用户）

  • 概述
  • 医院
  • 紧急医疗服务（EMS）
  • 军队
  • 其他的

7. 全球骨内装置市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他地区 (ROW)
    • 拉丁美洲
    • 中东和非洲

8. 全球骨内装置市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第九章 公司简介

  • Teleflex Incorporated
  • PERSYS MEDICAL
  • Cook
  • BD
  • Biopsybell
  • Pyng Medical Corp.
  • Aero Healthcare
  • Vidacare Corporation
  • Carefusion Inc.

第十章 附录

  • 相关分析
简介目录
Product Code: 40498

Intraosseous Devices Market Size And Forecast

Intraosseous Devices Market size was valued at USD 412.82 Million in 2024 and is projected to reach USD 592.94 Million by 2032, growing at a CAGR of 4.63% from 2026 to 2032.

The high prevalence of various diseases, such as cardiac arrest, emergencies including trauma, and increasing military engagements are expected to fuel the growth of the global Intraosseous Devices Market. Growth in the number of government and regulatory approvals is proving to be the foundation for the Intraosseous Devices Market. In addition, the increasing research and development activities as well as the increased awareness about public health is driving the market growth. The Global Intraosseous Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Intraosseous Devices Market Definition

Intraosseous devices are emergency medical equipment used for dealing with life-threatening conditions. Intraosseous devices can be used to supply medications and vital fluids in an emergency when venous access is absent. Intraosseous vascular is an alternative method for immediate medical intervention during emergency conditions. The device is quickly inserted into the medullary space of bone and accurate positioning of the device is indicated by the flow of intravenous fluid into the device.

If extravasation of the fluid around the insertion area occurs, the device is removed to prevent the growth of compartment syndrome. However, aspiration of bone marrow signifies another method to confirm the correct positioning of the device. Intraosseous devices are quick, easy, and effective. This device infuses medication directly into systemic circulation via bone marrow and is useful in emergency and delayed situations. These devices are used in the treatment of hematology/oncology patients, traumas, cardiac arrest, and diabetic patients.

Global Intraosseous Devices Market Overview

The increasing number of injuries, along with the failure of intravenous vascular access, is expected to fuel the market for intraosseous devices in the immediate future. Intraosseous infusion is a secure and efficient technology for cardiopulmonary resuscitation where other routes of administration struggle to achieve the desired impact.

The high prevalence of multiple diseases such as cardiac arrest, emergencies such as trauma, and rising military engagements are driving the global Intraosseous Devices Market. The increasing per capita income and a growing willingness to invest in advanced care are also fueling demand. Intraosseous infusion is most often used in pediatric pre-hospital emergencies where intravenous administration of fluids and medications is impossible. The rising prevalence of multiple disease types, as well as the number of traumatic surgeries, are likely to drive demand for these devices in the coming years.

The risks such as fractures during insertion, extravasation of drugs being managed, infections at the insertion site, as well as high medication costs, a shortage of medical expertise for nurses, and poor equipment management, are potential factors restraining the Intraosseous Devices Market. The rising regulatory approvals, mergers and acquisitions, and new markets created by developing economies present favorable growth opportunities in the market.

Global Intraosseous Devices Market Segmentation Analysis

The Global Intraosseous Devices Market is Segmented on the basis of Type, End-User, And Geography.

Intraosseous Devices Market, By Type

  • Manual
  • Semi-Automatic
  • Automatic

Based on Type, The market is segmented into Manual, Semi-Automatic, and Automatic. The automatic and semi-automatic segments are projected to grow because they are more technologically advanced than the manual.

Intraosseous Devices Market, By End-User

  • Hospitals
  • Emergency Medical Services (EMS)
  • Military
  • Others

Based on End-User, The market is segmented into Hospitals, Emergency Medical Services (EMS), Military, and Others. Due to the increased number of emergency situations, expanding medical personnel and specialized personnel, and growing patient population cases, the EMS segment is projected to lead the global Intraosseous Devices Market.

Intraosseous Devices Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, The Global Intraosseous Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has the strongest market share and is expected to grow in the coming years. The demand in North America is primarily led by an increase in the number of emergency cases, cardiac cases, and multiple diseases requiring immediate vascular access, as well as an increase in the acceptance of advanced products, a large number of medical practitioners, and specialized personnel, and the involvement of prominent players in these regions.

Key Players

The "Global Intraosseous Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Teleflex Incorporated, PERSYS MEDICAL, Cook, BD, Biopsybell, Pyng Medical Corp., Aero Healthcare, Vidacare Corporation, Carefusion Inc., and Others. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Mergers and Acquisitions
  • In December 2013, Teleflex Incorporated acquired Vidacare Corporation, a provider of intraosseous, or into the bone, access devices. This acquisition complemented the vascular access and specialty product portfolio of the company's critical care product group.
  • Product Launches and Product Expansions
  • In March 2020, SAM Medical launched SAM IO Intraosseous Access System for pre-hospital and hospital healthcare providers in the civilian and military sectors.
  • In November 2019, Piper Access, LLC received FDA 510(k) clearance for Piper Go-IO Intraosseous Infusion System from Piper Access.
  • In May 2018, TraumaFX, a division of Kforce Government Solutions, Inc. and a global provider of ruggedized human and canine medical training simulators, launched K9 Diesel, a canine medical simulator.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL INTRAOSSEOUS DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL INTRAOSSEOUS DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.2 Porters Five Force Model
  • 4.3 Value Chain Analysis

5 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Manual
  • 5.3 Semi-Automatic
  • 5.4 Automatic

6 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY END-USER

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Emergency Medical Services (EMS)
  • 6.4 Military
  • 6.5 Others

7 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL INTRAOSSEOUS DEVICES MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Teleflex Incorporated
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 PERSYS MEDICAL
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Cook
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 BD
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Biopsybell
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Pyng Medical Corp.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Aero Healthcare
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Vidacare Corporation
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Carefusion Inc.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments

10 APPENDIX

  • 10.1 Related Research